This site is intended for UK healthcare professionals
NICE recommends NHS use of innovative treatment for severe blood disorder
Patients suffering from a rare blood disorder may soon have a brand-new treatment after NICE recommended caplacizumab, with plasma exchange and immunosuppression for routine use on the NHS